Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 2Sarcoma 2Gastrointestinal 2Breast 2Head & Neck 1Genitourinary 1Dermatologic 1CNS 1

Conditions

Glioblastoma 5Glioma 3Brain Neoplasms 3Neuroectodermal Tumors 2Nervous System Diseases 2Neoplasms, Neuroepithelial 2Neoplasms, Nerve Tissue 2Gliosarcoma 2Sarcoma 1Neoplasms, Glandular and Epithelial 1Neoplasms, Germ Cell and Embryonal 1Neoplasms by Histologic Type 1Neoplasms 1Melanoma 1Lung Neoplasms 1Kidney Neoplasms 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Disease 1Central Nervous System Neoplasms 1Central Nervous System Diseases 1Carcinoma 1Breast Neoplasms 1Astrocytoma 1

Interventions

Cyclophosphamide 2pembrolizumab 1molibresib 1fludarabine phosphate 1fludarabine 1etoposide phosphate 1Temozolomide 1Sirolimus 1Pemetrexed 1Oncolytic Virotherapy 1Mesna 1Etoposide 1Craniotomy 1Celecoxib 1Carboplatin 1ADI PEG20 13-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl)piperidine-2,6-dione 11-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino(2,3-b)pyrazin-2(1H)-one 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma × Oncolytic Virotherapy × CNS × Clear all
NCT05961111 2023-07-27

A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors

Shanghai Yunying Medical Technology

Phase EARLY_PHASE1 Recruiting
20 enrolled
BreastCNSDermatologicGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Brain Neoplasms, Breast Neoplasms, Carcinoma, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Melanoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡